ACIU
AC Immune S.A.
NASDAQ · Healthcare · Biotechnology · CH
$2.86
−2.39%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 11.45x
- P/E 2028E
- 6.25x
- P/S forward
- 30.57x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 6.53x
- Price / sales
- 13.12x
- Price / cash flow
- -6.60x
Enterprise value
- Enterprise value
- $196.1M
- EV / sales
- 9.05x
- EV / EBITDA
- -3.77x
- EV / EBIT
- -3.59x
- Market cap
- $284.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026